Tolerogenic synthetic nanocarriers for allergy therapy Grant US-11779641-B2 United States of America 10 Oct 2023
Methods and compositions for attenuating anti-viral transfer vector immune responses Grant US-11633422-B2 United States of America 25 Apr 2023
Methods and compositions related to combined treatment with antiinflammatories and… Grant US-11426451-B2 United States of America 30 Aug 2022
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising… Grant US-11298342-B2 United States of America 12 Apr 2022
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific… Grant US-11235057-B2 United States of America 01 Feb 2022
FORMULATIONS AND DOSES OF PEGYLATED URICASE Application WO-2021092354-A1 World Intellectual Property Organisation (WIPO) 14 May 2021
Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-al… Grant US-10668053-B2 United States of America 02 Jun 2020
Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells Grant US-10441651-B2 United States of America 15 Oct 2019
Methods related to administering immunosuppressants and therapeutic macromolecules at a… Grant US-10434088-B2 United States of America 08 Oct 2019
Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells Grant US-10420835-B2 United States of America 24 Sep 2019
Methods comprising dosing combinations for reducing undesired humoral immune responses Grant US-10357483-B2 United States of America 23 Jul 2019
Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising… Grant US-10357482-B2 United States of America 23 Jul 2019
Methods of administering immunosuppressants having a specified pharmacodynamic effective… Grant US-10335395-B2 United States of America 02 Jul 2019
METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND… Application WO-2018169811-A1 World Intellectual Property Organisation (WIPO) 20 Sep 2018